XERS

Xeris Biopharma Holdings Inc

Jun 12 • 04:00PM ET

6.79

-0.14 -2.02 %

Healthcare • Drug Manufacturers - Specialty & Generic • USA • Small • NASD

Peers: AMRX SUPN KNSA ALKS INDV LNTH BHC HRMY TEVA VTRS

| Held by: VTI IWM VXF IWO XPH SCHA VTWO FESM VHT FYC

Scroll to Statements

Index	RUT	P/E	103.66	EPS (ttm)	0.07	Insider Own	4.12%	Shs Outstand	172.56M	Perf Week	9.87%
Market Cap	1.17B	Forward P/E	18.46	EPS next Y	0.37	Insider Trans	-4.91%	Shs Float	165.54M	Perf Month	5.60%
Enterprise Value	1.32B	PEG	-	EPS next Q	0.01	Inst Own	61.71%	Short Float	7.56%	Perf Quarter	24.36%
Income	12.01M	P/S	3.72	EPS this Y	4425.82%	Inst Trans	3.04%	Short Ratio	7.58	Perf Half Y	-2.16%
Sales	314.85M	P/B	90.05	EPS next Y	153.44%	ROA	3.39%	Short Interest	12.51M	Perf YTD	-13.50%
Book/sh	0.08	P/C	10.49	EPS next 5Y	-	ROE	-	52W High	10.08 -32.64%	Perf Year	53.62%
Cash/sh	0.65	P/FCF	24.67	EPS past 3/5Y	- -	ROIC	4.53%	52W Low	4.30 57.91%	Perf 3Y	142.07%
Dividend Est.	-	EV/EBITDA	27.11	Sales past 3/5Y	38.33% 70.20%	Gross Margin	82.45%	Volatility	4.99% 4.07%	Perf 5Y	71.90%
Dividend TTM	-	EV/Sales	4.19	EPS Y/Y TTM	123.74%	Oper. Margin	11.40%	ATR (14)	0.28	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	1.50	Sales Y/Y TTM	41.47%	Profit Margin	3.81%	RSI (14)	62.52	Recom	1.43
Dividend Gr. 3/5Y	- -	Current Ratio	2.12	EPS Q/Q	120.83%	SMA20	8.29%	Beta	0.70	Target Price	11.29
Payout	0.00%	Debt/Eq	19.87	Sales Q/Q	38.27%	SMA50	9.52%	Rel Volume	0.99	Prev Close	6.93
Employees	435	LT Debt/Eq	19.39	Earnings	May 07 BMO	SMA200	-3.85%	Avg Volume	1.65M	Price	6.79
IPO	Jun 21, 2018	Option/Short	Yes / Yes	EPS/Sales Surpr.	470.37% 3.28%	Trades		Volume	1,632,127	Change	-2.02%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)